Skip to search formSkip to main contentSkip to account menu

adalimumab

Known as: antibody d2e7, Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer, Adalimumab [Chemical/Ingredient] 
A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon… 
National Institutes of Health

Related topics

Related topics

20 relations
0.2 ML adalimumab 50 MG/ML Prefilled Syringe0.2 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]0.4 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]0.8 ML adalimumab 50 MG/ML Auto-Injector

Broader (2)

Anti-Inflammatory AgentsAntirheumatic Agents

Narrower (2)

D2E7 AntibodyHumira

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease
Citation for published version: Kennedy, NA, Warner, B, Johnston, EL, Flanders, L, Hendy, P, Ding, NS, Harris, R, Fadra, AS… 
2016
2016
Serum Calprotectin Versus Acute‐Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors
To compare the accuracy of serum calprotectin and acute‐phase reactants (C‐reactive protein [CRP] and erythrocyte sedimentation… 
Highly Cited
2013
Highly Cited
2013
Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.
Highly Cited
2013
Highly Cited
2013
Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease
Background/aimThe appearance of anti-adalimumab antibodies (AAAs) is associated with low serum adalimumab (ADA) trough levels and… 
Review
2013
Review
2013
Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?
Review
2012
Review
2012
Efficacy of systemic therapies for moderate‐to‐severe psoriasis: a systematic review and meta‐analysis of long‐term treatment
Background  Despite the chronicity of psoriasis, most systematic reviews focus on short‐term treatment. 
Review
2007
Review
2007
Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
Highly Cited
2007
Highly Cited
2007
The −308 tumour necrosis factor-α gene polymorphism predicts therapeutic response to TNFα-blockers in rheumatoid arthritis and spondyloarthritis patients
OBJECTIVE: To examine whether the G-to-A polymorphism at position -308 in the promoter of the tumour necrosis factor-alpha… 
Highly Cited
2005
Highly Cited
2005
Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure.
OBJECTIVE To assess the efficacy and safety of the fully human recombinant monoclonal anti-TNF antibody adalimumab in routine… 
2005
2005
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.
Anti-TNFalpha strategies can result in significant clinical benefits in rheumatoid arthritis (RA), but with an increased rate of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)